Joanne Ino Hsu MD PhD
Hematology/Oncology
https://connects.catalyst.harvard.edu/Profiles/display/Person/199916
Join to View Full Profile
75 Francis StBoston, MA 02115
Dr. Hsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2023 - 2027- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2021 - 2023
Baylor College of MedicineMD, 2013 - 2021- Baylor College of MedicinePhD, 2015 - 2019
Baylor College of MedicineClass of 2017
Certifications & Licensure
MA State Medical License 2021 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- is a synthetic-lethal target in-mutant leukemia cells.Linda Zhang, Joanne I Hsu, Etienne D Braekeleer, Chun-Wei Chen, Tajhal D Patel
Elife. 2024-06-18 - is a synthetic lethal target in-mutant leukemia cells.Linda Zhang, Joanne I Hsu, Etienne D Braekeleer, Chun-Wei Chen, Tajhal D Patel
Biorxiv. 2024-01-17 - 7 citationsExpanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM-associated syndromes.Michell M Lozano Chinga, Alison A Bertuch, Zeinab Afify, Kaylee Dollerschell, Joanne I Hsu
American Journal of Medical Genetics. Part A. 2023-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
